I am a
Home I AM A Search Login

Papers of the Week

2022 Apr 04

Pediatr Blood Cancer

Low-dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients.


Anghelescu DL, Ryan S, Wu D, Morgan KJ, Patni T, Li Y
Pediatr Blood Cancer. 2022 Apr 04:e29693.
PMID: 35373875.


Ketamine is an NMDA-receptor antagonist with analgesic and opioid-sparing properties. Although well studied in adults, more robust evidence supporting ketamine's use for pediatric pain management is needed. This retrospective study evaluates ketamine's opioid-sparing effectiveness in pediatric and young adult oncology and hematology patients.